G Forni

Istituti Clinici Scientifici Maugeri — Italy

Immunology and Microbiology · Life Sciences

32h-index2.9kcitations113works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunotherapy and Immune Responses(40), Immune Cell Function and Interaction(26), Virus-based gene therapy research(14), Monoclonal and Polyclonal Antibodies Research(14), Cancer Research and Treatments(13)

Publications113 total

The influence of gender on functional recovery activities in rehabilitation cardiology: a retrospective study in individuals with heart failure
European Heart Journal·2025
298 Cartilage oligomeric matrix protein DNA vaccine in transgenic mice developing autochthonous mammary carcinomas
European Journal of Cancer Supplements·2010
Zoledronic acid impairs mammary carcinogenesis in BALB/c mice transgenic for the Her-2/neu oncogene
Hematology Meeting Reports (formerly Haematologica Reports)·2009
Quantitative evaluation of DNA methylation by optimization of a differential-high resolution melt analysis protocol
Nucleic Acids Research·2009· 47 citedOpen Access
CCL16 Enhances the CD8<sup>+</sup> and CD4<sup>+</sup> T Cell Reactivity to Human Her-2 Elicited by Dendritic Cells Loaded with Rat Ortholog Her-2
International Journal of Immunopathology and Pharmacology·2008· 6 citedOpen Access
DNA immunization using constant-current electroporation affords long-term protection from autochthonous mammary carcinomas in cancer-prone transgenic mice
Cancer Gene Therapy·2007· 31 cited
ErbB2 transgenic mice: a tool for investigation of the immune prevention and treatment of mammary carcinomas. Curr Protoc Immunol.
2007· 14 cited
Adenovirus vaccination against neu oncogene exerts long-term protection from tumorigenesis in BALB/neuT transgenic mice
2007· 5 cited
Anti-HER-2 DNA vaccine protects Syrian hamsters against squamous cell carcinomas
British Journal of Cancer·2005· 6 citedOpen Access
A Limited Autoimmunity to p185<sup>neu</sup> Elicited by DNA and Allogeneic Cell Vaccine Hampers the Progression of Preneoplastic Lesions in HER-2/NEU Transgenic Mice
International Journal of Immunopathology and Pharmacology·2005· 9 cited
Neutrophils in the Antitumoral Immune Response
2003· 95 cited
Prevention by delay: nonspecific immunity elicited by IL-12 hinders Her-2/neu mammary carcinogenesis in transgenic mice.
PubMed·2002· 5 cited
Therapy of lung metastases through combined vaccination with carcinoma cells engineered to release IL-13 and IFN-γ
Gene Therapy·2001· 6 citedOpen Access
Biased activation of human T lymphocytes due to low extracellular pH is antagonized by B7/CD28 costimulation
European Journal of Immunology·2001· 83 citedOpen Access
Insertion of the DNA for the 163–171 peptide of IL1β enables a DNA vaccine encoding p185neu to inhibit mammary carcinogenesis in Her-2/neu transgenic BALB/c mice
Gene Therapy·2001· 52 citedOpen Access
Regulation of interferon-gamma receptor (INF-gammaR) chains: a peculiar way to rule the life and death of human lymphocytes.
PubMed·2001· 32 cited
Antitumor vaccination: where we stand.
PubMed·2000· 76 cited
Ability of systemic interleukin-12 to hamper progressive stages of mammary carcinogenesis in HER2/neu transgenic mice.
PubMed·2000· 92 cited
Analysis of mammary carcinoma onset and progression in HER-2/neu oncogene transgenic mice reveals a lobular origin.
PubMed·1999· 107 cited
Specific and nonspecific immunity in the prevention of spontaneous tumours
Immunology Today·1999· 21 cited
page 1 of 6Next →

Frequent Co-authors

Mirella Giovarelli(17), Piero Musiani(9), Angela Santoni(8), Federica Cavallo(8), Francesco Novelli(7), Emma Di Carlo(6), C Jemma(6), Alessandra Allione(5), Patrizia Nanni(5), Pier‐Luigi Lollini(5), Marco Forni(5), G Cortesina(5), Andrea Modesti(4), Paola Bernabei(4), Santo Landolfo(4), Robin Foà(4), Alessandra Modesti(3), K Boggio(3), L Rigamonti(3), Elena Quaglino(3)